Literature DB >> 1577846

Cell proliferation in human tumours growing in nude mice: renal cell carcinomas, larynx and hypopharynx carcinomas.

B Maurer-Schultze1, I D Bassukas, M Böswald, M Harasim.   

Abstract

Cell proliferation of 51 human renal cell carcinomas and 9 larynx and hypopharynx carcinomas has been studied in vitro and using xenotransplants. The proliferative activity ([3H]thymidine labelling index) increases during the first passages in nude mice and then remains almost constant throughout subsequent passages. A comparison of cell kinetic parameters of 8 human renal cell carcinomas, 1 hypopharynx and 2 larynx carcinomas, with data of xenografts and of human tumours in situ published up to now, shows that the cell kinetic parameters of human tumour xenografts presently studied range between those of human tumours in situ and those of autochthonous or transplantable mouse tumours. S-phase durations and potential doubling times are considerably shorter in xenotransplants than in human tumours in situ, whereas the cycle time is about the same. This means that the growth fraction increases considerably after xenotransplantation. This change of human tumour cell proliferation after transplantation into nude mice should be kept in mind if one wishes to draw conclusions from the nude mouse model on conditions in human beings, particularly with respect to therapeutic regimens, which are frequently tested in the nude mouse model.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1577846     DOI: 10.1007/bf01208614

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  81 in total

1.  Significance of growth rates, cell kinetics, and histology in the irradiation and chemotherapy of squamous cell carcinoma of the mouth.

Authors:  M Friedman; C Nervi; C Casale; G Starace; G Arcangeli; G Page; E Ziparo
Journal:  Cancer       Date:  1973-01       Impact factor: 6.860

2.  Thymidine labeling index, flow cytometric S-phase measurement, and DNA index in human tumors. Comparisons and correlations.

Authors:  J S Meyer; M D Coplin
Journal:  Am J Clin Pathol       Date:  1988-05       Impact factor: 2.493

3.  Mechanism of growth retardation of the adenocarcinoma EO 771.

Authors:  I D Bassukas; B Maurer-Schultze
Journal:  Radiat Environ Biophys       Date:  1987       Impact factor: 1.925

4.  Growth of head and neck squamous cell carcinoma in nude mice: potentiation of laryngeal carcinoma by 17 beta-estradiol.

Authors:  K D Somers; M Koenig; G L Schechter
Journal:  J Natl Cancer Inst       Date:  1988-07-06       Impact factor: 13.506

5.  Cell proliferation in human melanoma.

Authors:  S Shirakawa; J K Luce; I Tannock; E Frei
Journal:  J Clin Invest       Date:  1970-06       Impact factor: 14.808

6.  Growth and metastatic behavior of human tumor cells implanted into nude and beige nude mice.

Authors:  S Naito; R Giavazzi; S M Walker; K Itoh; J Mayo; I J Fidler
Journal:  Clin Exp Metastasis       Date:  1987 Apr-Jun       Impact factor: 5.150

7.  Transplantation of human renal carcinomas into athymic mice.

Authors:  R V Clayman; R S Figenshau; A Bear; C Limas
Journal:  Cancer Res       Date:  1985-06       Impact factor: 12.701

8.  Establishment of a human large cell lung tumor line (QU-DB) with metastatic properties in athymic mice.

Authors:  S P Cole; B G Campling; D F Dexter; J J Holden; J C Roder
Journal:  Cancer       Date:  1986-08-15       Impact factor: 6.860

9.  Changes in histology and cell kinetics during the growth course of xenografted squamous cell carcinoma.

Authors:  J Wennerberg; R Willén; C Tropé
Journal:  Arch Otolaryngol Head Neck Surg       Date:  1988-07

10.  Prognostic significance of the DNA content of renal carcinoma.

Authors:  J B deKernion; E Mukamel; A W Ritchie; B Blyth; J Hannah; R Bohman
Journal:  Cancer       Date:  1989-10-15       Impact factor: 6.860

View more
  2 in total

1.  Evidence for a narrow range of growth patterns of malignant tumors and embryos of different species.

Authors:  I D Bassukas
Journal:  Naturwissenschaften       Date:  1993-08

2.  A validated tumorgraft model reveals activity of dovitinib against renal cell carcinoma.

Authors:  Sharanya Sivanand; Samuel Peña-Llopis; Hong Zhao; Blanka Kucejova; Patrick Spence; Andrea Pavia-Jimenez; Toshinari Yamasaki; David J McBride; Jessica Gillen; Nicholas C Wolff; Lorraine Morlock; Yair Lotan; Ganesh V Raj; Arthur Sagalowsky; Vitaly Margulis; Jeffrey A Cadeddu; Mark T Ross; David R Bentley; Wareef Kabbani; Xian-Jin Xie; Payal Kapur; Noelle S Williams; James Brugarolas
Journal:  Sci Transl Med       Date:  2012-06-06       Impact factor: 17.956

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.